Nuvasive Inc (NUVA) 66.74 $NUVA Zimmer Biomet's LDR

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2016 at 7:13 AM

Nuvasive Inc (NUVA) 66.74 $NUVA

Zimmer Biomet's LDR Buyout On Track, Dental Still a Pain
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 8:45AM CDT
On Sep 2, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
ZBH: 129.40 (+1.05), GWPH: 82.73 (+0.45), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)

Bet on These 5 Profitable Stocks for Big Returns
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 6:26AM CDT
A company with strong profit generating capabilities usually has the proficiency to meet business expenses and create steady returns for investors.
FB: 126.51 (+0.34), TPH: 13.44 (+0.07), PE: 34.86 (+0.57), CORT: 5.31 (-0.04), NUVA: 66.74 (+0.68)

NuVasive to Participate in Investor Events in September 2016
Marketwired - Fri Sep 02, 6:00AM CDT
SAN DIEGO, CA--(Marketwired - September 02, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in September 2016:
WFC: 50.55 (+0.12), NUVA: 66.74 (+0.68)

Becton, Dickinson Hits 52-Week High on Solid Q3, Outlook
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 10:13AM CDT
Shares of Becton, Dickinson and Company (BDX) scaled a new 52-week high of $178.79 on Jul 31, eventually closing nominally lower at $177.21.
BABY: 40.64 (+0.93), BDX: 177.32 (+0.30), MASI: 59.90 (+0.47), NUVA: 66.74 (+0.68)

Inogen Hits 52-Week High on Solid Q2 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:01AM CDT
Share price of Inogen Inc (INGN) rallied to a new 52-week high of $59 on Aug 30, eventually closing a tad bit lower at $58.46.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), INGN: 58.11 (+0.16), NUVA: 66.74 (+0.68)

Veeva Systems (VEEV) Q2 Earnings, Revenues Top; View Up
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:57AM CDT
Veeva Systems (VEEV) reported adjusted earnings of 15 cents per share in the second-quarter fiscal 2017, a 20.9% increase on a year-over-year basis.
VEEV: 40.74 (+0.51), BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), NUVA: 66.74 (+0.68)

NuVasive: Strong Q2 Results, Overseas Holds Solid Prospect
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:13AM CDT
NuVasive (NUVA) posted strong results in the second quarter of 2016, with both earnings and revenues squarely beating the Zacks Consensus Estimate
GWPH: 82.73 (+0.45), QDEL: 21.58 (-0.16), LNTH: 9.40 (-0.10), NUVA: 66.74 (+0.68)

BioTelemetry Gets CE Mark for Holter Monitoring Software
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:38AM CDT
BioTelemetry (BEAT) recently announced the receipt of CE mark for its Holter analysis software.
MASI: 59.90 (+0.47), BEAT: 18.82 (+0.12), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)

Luminex Poised on Pipeline Strength, System Sales Upbeat
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:19AM CDT
Austin-based Luminex (LMNX) is well poised on pipeline strength and solid system sales.
MASI: 59.90 (+0.47), QDEL: 21.58 (-0.16), LMNX: 21.12 (+0.19), NUVA: 66.74 (+0.68)

Phibro Animal Health (PAHC) Q4 Earnings Top, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 6:51AM CDT
Phibro's (PAHC) fiscal fourth-quarter bottom line comfortably exceeding the Zacks Consensus Estimate, while its revenues expanded in low-single-digit on a year-over-year basis.
GWPH: 82.73 (+0.45), PAHC: 25.86 (+0.27), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)

Medtronic on Track with Covidien Synergy, Buys HeartWare
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:02AM CDT
On Aug 26, 2016, we issued an updated research report on Medtronic plc (MDT).
MDT: 87.32 (+0.34), GWPH: 82.73 (+0.45), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)

Hill-Rom (HRC) Hits New 52-Week High on Solid Q3 Results
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:08AM CDT
Shares of Hill-Rom (HRC) rallied to a new 52-week high of $59.45 on Aug 26.
GWPH: 82.73 (+0.45), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68), HRC: 59.97 (+0.72)

Uptrend Call Working As NuVasive Stock Rises 45.1% (NUVA)
Comtex SmarTrend(R) - Fri Aug 26, 12:57PM CDT
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on March 4th, 2016 at $43.48. In approximately 6 months, NuVasive has returned 45.12% as of today's recent price of $63.10.
NUVA: 66.74 (+0.68)

Medtronic (MDT) Beats Q1 Earnings, Revenues Closely In-Line
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:29PM CDT
Medtronic plc (MDT)'s reported financial results for first-quarter fiscal 2017. Adjusted earnings per share (EPS) in the reported quarter came in at $1.03, 2 cents ahead of the Zacks Consensus Estimate.
MDT: 87.32 (+0.34), GWPH: 82.73 (+0.45), QDEL: 21.58 (-0.16), NUVA: 66.74 (+0.68)

PRA Health Sciences (PRAH) Hits 52-Week High on Solid Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:59AM CDT
Share price of PRA Health Sciences (PRAH) rallied to a new 52-week high of $52.72 on Aug 23, eventually closing a tad bit higher at $52.59.
MASI: 59.90 (+0.47), PRAH: 50.38 (-0.18), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)

BioTelemetry Forms Partnership with Bloomlife, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 7:57AM CDT
BioTelemetry announced a strategic partnership with Bloom Technologies.
MASI: 59.90 (+0.47), BEAT: 18.82 (+0.12), CRY: 16.23 (+0.39), NUVA: 66.74 (+0.68)

Medtronic's HeartWare Takeover Complete for $1.1 Billion
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 4:54AM CDT
With HeartWare in its kitty, Medtronic (MDT) will now gracefully lead the global VAD market for heart failure patients.
MDT: 87.32 (+0.34), GWPH: 82.73 (+0.45), QDEL: 21.58 (-0.16), HTWR: 58.20 (+0.22), NUVA: 66.74 (+0.68)

Akers Biosciences OxiCheck Study Results Positive, Stock Up
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:21AM CDT
Akers Biosciences Inc. (AKER) recently announced favorable clinical results for its BreathScan OxiCheck disposable breath test.
CAH: 79.73 (+0.03), QDEL: 21.58 (-0.16), AKER: 3.66 (+0.13), NUVA: 66.74 (+0.68)

Alere (ALR) Receives FDA Approval for RSV Molecular Test
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 7:16AM CDT
Alere recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test.
QDEL: 21.58 (-0.16), LNTH: 9.40 (-0.10), ALR: 39.13 (+0.69), NUVA: 66.74 (+0.68)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...